Research Centers

The National Institutes of Health (NIH) awarded grants to three Collaborative Research Centers (CRCs) and one Data Management Coordinating Center.

Logo for Columbia University Mailman School of Public Health
Center for Solutions for ME/CFS
The Center for Solutions for ME/CFS (CfS for ME/CFS) is an interdisciplinary, inter-institutional center comprising clinicians, clinical investigators, and basic scientists who are committing to working together to understand the pathogenesis of ME/CFS and develop evidence-based strategies for interventions that prevent and mitigate disease. The team initially coalesced with an NIH call to respond to spurious reports linking xenotropic murine leukemia virus-related virus (XMRV) to ME/CFS. The team consolidated with support from the Hutchins Family Foundation Chronic Fatigue Initiative (CFI) and a crowd-funding initiative, the Microbe Discovery Project, to explore the role of infection and immunity in disease and identify biomarkers for diagnosis through functional genomic, epigenetic, proteomic, and metabolomic discovery.
The CfS for ME/CFS is designed to rapidly adapt to the insights and opportunities that are continuously emerging in the field of ME/CFS research. Accordingly, we are a center without walls — we recruit new investigators nationally and internationally based on their commitment and expertise rather than their institutional affiliation. We continuously assess our research priorities and experimental strategies to ensure that resources are optimally invested.

In our three main projects, we will explore the role of infection and immunity in ME/CFS, work to understand the roles of metabolomics and gene expression in ME/CFS, and work with the ME/CFS community and clinicians to design a mobile app ("myME/CFS") to help patients and physicians acquire valuable longitudinal data and personally as well as clinically manage the illness.
Photo: The Columbia Center for Solutions for ME/CFS team The Columbia Center for Solutions for ME/CFS team

Partnerships

Columbia University proudly partners with Solve ME/CFS Initiative and #MEAction to encourage community involvement in its research efforts. Please visit the Community Page of the CfS for ME/CFS website on the Center for Infection and Immunity's website for more information about community outreach and resources.

Center Director, W. Ian Lipkin, MD
Photo: Center Director, W. Ian Lipkin, MD
Center Director, W. Ian Lipkin, MD W. Ian Lipkin, MD, is internationally recognized for his contributions to global public health through the innovative methods he developed for infectious diseases diagnosis, surveillance, and discovery. Most notably, he had the first use of subtractive cloning in microbial discovery and the first use of next generation sequencing for investigating outbreaks. Dr. Lipkin also developed gene capture technologies, including VirCapSeq-VERT and BacCapSeq as well as multiplexed serological assays to detect vector-borne diseases. These advances have been critical in replacing culture-dependent methods of global health management by creating new criteria for disease causation and de-linking spurious associations between putative agents and diseases. Such examples include refuting the MMR vaccine having a role in autism and XMRV in ME/CFS. Dr. Lipkin has been at the forefront of outbreak response to many of the world's recent outbreaks, including West Nile Virus in NYC (1999), SARS in China (2003), MERS in Saudi Arabia (2012-2016), Zika in the United States (2016), and encephalitis in India (2017). He promotes public health awareness via print and broadcast media and also served as the scientific advisor for the Steven Soderberg film Contagion. Some of his most prestigious honors include Pew Scholar (Biomedical Sciences), Walter Reed Distinguished Lecturer, the Drexel Prize in Translational Medicine, the Mendel Medal (Villanova University), and the International Science and Technology Cooperation Award of the People's Republic of China. He is the Director of the Center for Solutions for ME/CFS, the Director for the Center for Research in Diagnostics and Discovery, and the Director for the Center of Infection and Immunity with the Mailman School of Public Health at Columbia University.
Deputy Center Director, Dana March Palmer, PhD, MPH
Photo: Deputy Center Director, Dana March Palmer, PhD, MPH
Deputy Center Director, Dana March Palmer, PhD, MPH Dana March Palmer, PhD, MPH, is an Assistant Professor of Epidemiology and the Associate Dean for Educational Initiatives at Columbia University's Mailman School of Public Health. She is a social and psychiatric epidemiologist whose research addresses the intersection of physical and mental illness, from etiology to identifying patient subgroups who respond optimally to interventions. Dr. Palmer is currently engaged in the identification of subgroups in ME/CFS by uncovering unique patterns in survey, clinical, and laboratory data. She is also invested in generating interest in ME/CFS research through mentorship of the next generation of scientific leaders. Dr. Palmer's work has been featured in Scientific American. She has also written for the New York Times and USA Today and has served as a scientific commentator for CBS This Morning, Al Jazeera America, ABC, and NPR. Dr. Palmer serves as the Deputy Director of the Center for Solutions for ME/CFS within the Center for Infection and Immunity.
Project Coordinator, Paul Newswanger, MPH
Photo: Project Coordinator, Paul Newswanger, MPH
Project Coordinator, Paul Newswanger, MPH Paul Newswanger, MPH, holds a BS in Neurobiology, Physiology, and Behavior and a BA in Music from UC Davis. He received his MPH in Sociomedical Sciences from Columbia University in 2017. He has served as a casework liaison manager for the American Red Cross in the Hurricane Sandy Relief Effort, a clinical coordinator for St Jude Medical, and a Research Assistant for the Bard Prison Initiative and Columbia University. Mr. Newswanger serves as the Project Coordinator for the Center for Solutions for ME/CFS.

Interested in participating in research?

Logo for Cornell University
The Cornell ME/CFS Collaborative Research Center
The Cornell ME/CFS Collaborative Research Center conducts and promotes interdisciplinary research to identify the causes, biomarkers, and pathophysiology of ME/CFS with the goal of developing diagnostic and treatment methods. The Center draws expertise from Cornell's flagship campus and medical college, a local research institute, Ithaca College, and medical practices, utilizing their collective scientific and clinical expertise in advanced neuroimaging techniques, proteomics, metabolism, molecular biology, and genetics.
As an NIH Collaborative Research Center (CRC), Cornell will focus on three main research projects designed to provide unique insights into ME/CFS by studying brain images, molecular markers in blood, and biologic and physiologic characteristics of exercise-induced post-exertional malaise (PEM). PEM is a hallmark symptom of ME/CFS. To simulate PEM for data-gathering purposes, researchers will conduct cardiopulmonary exercise tests using stationary bikes at Weill Cornell Medicine, the Ithaca College Wellness Clinic, and at the medical practice of John Chia, MD, in Los Angeles. The first project uses advanced brain imaging techniques, including MRI and PET, to look for markers of neuroinflammation and oxidative stress before and after exercise, to see if differences in the markers are linked with the disease. The second project will examine proteins, small molecules, and microRNAs in extracellular vesicles before and after exercise to find out whether the contents of vesicles are associated with ME/CFS symptoms. In the third project, Cornell researchers will sequence the RNA in individual white blood cells in people with ME/CFS and healthy individuals before and after exercise, to learn more about the role of gene regulation and the immune system in the disease.
Photo: The Cornell ME/CFS CRC team Credit: Dave Burbank, Cornell Photography The Cornell ME/CFS CRC team Credit: Dave Burbank, Cornell Photography

Partnerships

Cornell University and Weill Cornell Medicine are collaborating with Ithaca College, where the Clinical Core of the Center is located, and with Frank Schroeder, PhD, of Cornell's Boyce Thompson Institute. Physicians Susan Levine, Geoffrey Moore, and John Chia are screening individuals for inclusion in the studies. Betsy Keller, PhD, co-directs the Clinical Core at Ithaca College with Geoffrey Moore, MD. The Cornell CRC is also partnering with Solve ME/CFS Initiative and the American ME and CFS Society to encourage community involvement in research and outreach efforts.

Center Director, Maureen Hanson, PhD
Photo: Center Director, Maureen Hanson, PhD Photo by Dave Burbank
Center Director, Maureen Hanson, PhD Maureen R. Hanson, PhD, is the Liberty Hyde Bailey Professor in the Department of Molecular Biology & Genetics at Cornell University. She directs Cornell's Center for Enervating NeuroImmune Disease and the NIH ME/CFS CRC's project concerning extracellular vesicles as possible mediators or sources of biomarkers for the disease, particularly after an exercise challenge. Students in Cornell's graduate programs in Genetics and Development in Biochemistry, Molecular and Cell Biology are performing thesis research on ME/CFS under her supervision. Dr. Hanson's research on the pathophysiology of ME/CFS has encompassed mitochondrial genetics, the gut microbiota, cellular metabolism, gene expression, and immune cell function.
Project Director, Andrew Grimson, PhD
Photo: Project Director, Andrew Grimson, PhD Photo by Dave Burbank
Project Director, Andrew Grimson, PhD Andrew Grimson, PhD, is an Associate Professor in the Department of Molecular Biology and Genetics at Cornell University. The Grimson laboratory specializes in the genomics of gene regulation, the mechanisms used by cells to increase or decrease the production of gene products. Although the causes of ME/CFS remain unknown, substantial evidence suggests that immune cell impairment (or dysregulation) is an underlying cause or major consequence of the disease. To better understand the contribution of specific impaired leukocytes (or white blood cells) to ME/CFS, Dr. Grimson will investigate gene regulation defects from blood samples collected from individuals with ME/CFS and healthy individuals, before and after an exercise session. This novel approach will provide definitive data and better understanding of gene regulatory changes in individuals with ME/CFS.
Project Director, Dikoma C. Shungu, PhD
Photo: Project Director, Dikoma C. Shungu, PhD
Project Director, Dikoma C. Shungu, PhD Dikoma C. Shungu, PhD, is Professor of Physics in Radiology at Weill Cornell Medical Center. His research, conducted at the Medical Center's Laboratory for Advanced Magnetic Resonance Spectroscopy (MRS), focuses on the development of MRS and magnetic resonance imaging (MRI) methods for biological and clinical research. In his project, Dr. Shungu will use advanced neuroimaging techniques to test and validate a promising pathophysiological model of ME/CFS, which suggests that oxidative stress and neuroinflammation are important mechanisms in the cause and development of this disease. In addition to his prior work on ME/CFS, Dr. Shungu has used neuroimaging methods to study fibromyalgia, Gulf War Illness, schizophrenia, major depression, Parkinson's disease, and other brain disorders and diseases.
Center Clinical Core Co-Lead, Betsy Keller, PhD
Photo: Center Clinical Core Co-Lead, Betsy Keller, PhD
Center Clinical Core Co-Lead, Betsy Keller, PhD Betsy Keller, PhD, is Co-director of the Clinical Core for the Cornell University ME/CFS CRC. She is a professor and clinician at Ithaca College who has tested persons ill with ME/CFS since 2003 for the purposes of research and to provide an objective assessment of functional capacity and ability to recover from physical work. Often these individuals seek an objective indication of illness status to apply for disability benefits. In addition to her research and clinical work, she served on the committee for the Institute of Medicine to study and develop clinical criteria for the diagnosis of ME/CFS, as well as two sub-committees for NIH NINDS to identify common data elements for the study of ME/CFS.
Center Clinical Core Co-Lead, Geoff Moore, MD
Photo: Center Clinical Core Co-Lead, Geoff Moore, MD
Center Clinical Core Co-Lead, Geoff Moore, MD Geoff Moore, MD, is Co-director of the Clinical Core for the Cornell University ME/CFS CRC. He has worked extensively with patients with chronic diseases and health disparities. In addition, Geoff has a strong research background with grant-funded work in basic physiological mechanisms of exercise intolerance in chronic disease. He co-edited texts for the American College of Sports Medicine (ACSM) on Exercise Management for Persons with Chronic Diseases and Disabilities, and contributed to ACSM'S Resource Manual for the Guidelines for Exercise Testing and Prescription. Clinically, his work has focused on lifestyle management to improve health status in addition to sports medicine. He is owner of Healthy Living & Exercise Medicine Associates and Chief Medical Officer of Wellcoaches Digital.
Center Manager, Carl Franconi, MS
Photo: Center Manager, Carl Franconi, MS
Center Manager, Carl Franconi, MS Carl Franconi, MS, is Center Manager for the Cornell University ME/CFS CRC and Manager of Dr. Hanson's lab in the Department of Molecular Biology and Genetics at Cornell University. He has a foundation in microbiology and molecular biology that started at the University of South Florida where he earned a BS in Microbiology and a MS in Cell & Molecular Biology. Prior to joining the Center, Carl was a Biological Administrator and Scientist for an ISO 17025 accredited laboratory at the Florida Department of Agriculture and Consumer Services. He brings laboratory and data management, collaborator coordination, and quality assurance experience.
Center Integrative Data Analysis Core Co-Lead, Jennifer Grenier, PhD
Photo: Center Integrative Data Analysis Core Co-Lead, Jennifer Grenier, PhD
Center Integrative Data Analysis Core Co-Lead, Jennifer Grenier, PhD Jen Grenier, PhD is Co-Lead of the Integrative Data Analysis Core (IDAC) and Director of the Transcriptional Regulation and Expression (T-REx) Facility and the Genomics Innovation (GI) Hub at Cornell University. She has 20 years of experience in technology development, most recently in project management and data analysis for genomics applications. Prior to creating the T-REx and GI labs at Cornell, Jen worked at the Broad Institute in Cambridge, MA, and at small biotechnology companies in Madison, WI. Jen has a PhD in Genetics from the University of Wisconsin-Madison and a BS in Biological Sciences from Stanford.
Center Integrative Data Analysis Core Co-Lead, Elizabeth Sweeney, PhD
Photo: Center Integrative Data Analysis Core Co-Lead, Elizabeth Sweeney, PhD
Center Integrative Data Analysis Core Co-Lead, Elizabeth Sweeney, PhD Elizabeth Sweeney, PhD is Co-Lead of the IDAC and an Assistant Professor in the Division of Biostatistics and Data Science at Weill Cornell Medicine. Her expertise is in the statistical analyses of magnetic resonance-based imaging data, including image segmentation, image normalization and harmonization, cross-sectional and longitudinal modeling, as well as software development. Prior to joining Cornell, she was Senior Data Scientist at Covera Health, Lecturer at Columbia School of Public Health, Senior Quantitative Scientists at Flatiron Health, and a postdoctoral fellow at Rice University. She holds a PhD degree in Biostatistics from Johns Hopkins Bloomberg School of Public Health.

Dr. Maureen Hanson on Immune System Function of ME/CFS at Inaugural Harvard Symposium

Dr. Maureen Hanson on Immune Dysregulation in ME/CFS at 14th Invest in ME Research International ME Conference

Dr. Alexandra Mandarano on altered T cell metabolism and dysregulated cytokine associations in ME/CFS

Interested in participating in research?

Logo for The Jackson Laboratory
The Jackson Laboratory ME/CFS Collaborative Research Center
The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution whose mission is to discover precise genomic solutions for human disease. As an NIH CRC, JAX will bring together experts in computational biology, statistics, chemistry, immunology, metabolomics, and microbiology to test an emerging hypothesis about the interplay between a patient's immune system, metabolism, and microbiome in the onset and progression of ME/CFS.
Blood and stool samples from individuals with ME/CFS and healthy controls will be collected at multiple time points at the Bateman Horne Center in Salt Lake City, UT. Samples will then be analyzed at the JAX CRC to explore changes in the immune system, metabolome, and gut microbiome of individuals with ME/CFS over time and in comparison to healthy individuals. The role of the gut microbiome, or the collection of microorganisms that live in the digestive tract of each individual, has become an area of particular interest in ME/CFS. The CRC will investigate how the gut microbiome interacts with the immune system to cause disease and how it contributes to disease severity. The research project will generate a highly detailed longitudinal collection of clinical and biological ME/CFS data that will be analyzed using advanced computational technologies such as machine learning approaches. Finding a biological basis for ME/CFS and related biomarkers could lead to faster diagnosis and personalized treatment approaches.
Photo: The Jackson Laboratory ME/CFS Research Team The Jackson Laboratory ME/CFS Research Team

Partnerships

JAX and the Bateman Horne Center are clinical partners for ME/CFS research; the Bateman Horne Center's clinical research is jointly led by Lucinda Bateman, MD, and Suzanne Vernon, PhD.

Center Director, Derya Unutmaz, MD
Photo: Center Director, Derya Unutmaz, MD
Center Director, Derya Unutmaz, MD Derya Unutmaz, MD, is a Professor and Principal Investigator at The Jackson Laboratory for Genomic Medicine. He is also the Center Director of JAX's ME/CFS CRC. His research team investigates the biology of the human immune system, and the relevance of human T cell subsets to normal immune response, diseases, and aging. His expertise in immunology, microbiology, and pathology has led to advances in the understanding of how T cells contribute to immune suppression during infection and other chronic diseases.
Center Associate Director, Julia Oh, PhD
Photo: Center Associate Director, Julia Oh, PhD
Center Associate Director, Julia Oh, PhD Julia Oh, PhD, is an Assistant Professor at the Jackson Laboratory for Genomic Medicine. She is the Center Associate Director of JAX's CRC. Her laboratory focuses on the human microbiome and on exploring the complex interactions between the host and its microbes. Dr. Oh is interested in the potential of the human microbiome to deliver treatments for various diseases. Her work has led to important implications for how the microbiome is linked to disease.
Center Program Manager, Courtney Gunter, MS
Photo: Center Program Manager, Courtney Gunter, MS
Center Program Manager, Courtney Gunter, MS Courtney Gunter, MS, is a Research Program Administrator at the Jackson Laboratory for Genomic Medicine and is the Center Program Manager of JAX's CRC. She has a background in biotechnology and in microbiology and is a member of Dr. Unutmaz's lab, studying the human immune system and its link to chronic disease. She focuses on data analysis and management, coordination and communication between collaborators, and community outreach.
Center Clinical Core Lead, Lucinda Bateman, MD
Photo: Center Clinical Core Lead, Lucinda Bateman, MD
Center Clinical Core Lead, Lucinda Bateman, MD Lucinda Bateman, MD, is a clinician at the Bateman Horne Center and is the Center Clinical Core Lead of JAX's CRC. She founded the Bateman Horne Center as a specialty research clinic where individuals with ME/CFS receive diagnoses, management, and treatment plans designed to improve their lives. Dr. Bateman is interested in advancing a clinical care model and driving research participation to drive progress in the ME/CFS field.
Center Clinical Core Co-Lead, Suzanne Vernon, PhD
Photo: Center Clinical Core Co-Lead, Suzanne Vernon, PhD
Center Clinical Core Co-Lead, Suzanne Vernon, PhDSuzanne D. Vernon, PhD, is the Research Director at the Bateman Horne Center and is the Center Clinical Core Co-Lead of JAX's CRC. She has focused her research career on identifying biomarkers and causes of ME/CFS. Dr. Vernon brings her experience, connections, and collaborations to the Bateman Horne Center to build a research program focused on developing objective diagnosis and evidence-informed treatments for ME/CFS.

Solving the Mystery of Chronic Fatigue Syndrome

Research into the Microbiome for ME/CFS

Solving the Mystery of Chronic Fatigue Syndrome

Explore issues that individuals with ME/CFS experience and learn about challenges faced by doctors and scientists as they work to solve the mystery of chronic fatigue syndrome.

Q&A: Life on the Front Line of ME/CFS Research

JAX program manager Courtney Gunter talks about life on the front line of ME/CFS research.

Interested in participating in research?

Logo for The ICanCME
Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network
The Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, with headquarters located at the Sainte-Justine University Hospital Research Centre in Montreal, is a national research network funded by the Canadian Institutes of Health Research (CIHR). Directed by Alain Moreau, PhD, the research network comprises an interdisciplinary and collaborative team of researchers, clinical scientists, trainees, patients, caregivers, and advocates who are committed to working together to support the ICanCME Research Network's vision, mission, and strategic pillars.
The vision of the network is to focus on initiating, supporting, and sustaining innovative and collaborative Myalgic Encephalomyelitis (ME) research in Canada. Our bold mission is committed to a patient-centred research program from discovery to implementation science to study and understand the complex pathophysiology of ME. Ultimately the network aims to establish collaborative work by bringing different fields of study together to develop novel approaches to test and treat ME.

The activities of the network are centered around three strategic pillars:
  1. Build a catalyst-accelerator program to fill existing gaps in ME research, stimulate new discoveries and sustain excellence in ME research in Canada.
  2. Develop a sustainable research infrastructure for ME and implement the integration and standardization of databases and biobanking procedures.
  3. Develop talent to enhance ME research capacity and excellence in research.

The network will play an important role in coordinating efforts of Canadian and international stakeholders, and transforming the ME research landscape in Canada and beyond.

Partnerships

The ICanCME Research Network has formed partnerships with three national organizations, Millions Missing Canada, Action CIND, and the National ME/FM Action Network, as well with several provincial ME organizations including l'Association Québécoise de l'Encéphalomyélite Myalgique (AQEM), the ME/FM Society of BC, and the broader patient community to initiate, develop and sustain an ME research ecosystem across Canada.

Network Director, Alain Moreau, PhD
Photo: Network Director, Alain Moreau, PhD
Network Director, Alain Moreau, PhD Alain Moreau, PhD, is a Full Professor in the Faculty of Dentistry (Stomatology Department), cross-appointed to the Biochemistry and Molecular Medicine Department in the Faculty of Medicine at Université de Montréal. He served as Director of Research and Chief Scientific Officer of Sainte-Justine University Hospital (2013-2016). He is currently Director of two national research networks - the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network and the Network for Canadian Oral Health Research (NCOHR) - funded by the Canadian Institutes of Health Research (CIHR), and serves on the Advisory Board of CIHR’s Institute of Musculoskeletal Health and Arthritis (IMHA).

Dr. Moreau is an internationally recognized expert on the molecular genetics of pediatric scoliosis. His discoveries led to multiple peer-reviewed papers, international conferences as a guest speaker, several awards as well as 60 patents covering innovative diagnostic tests and therapeutic molecules. Dr. Moreau is the co-founder and Chief Scientific Officer of Inception Therapeutic Inc., a start-up based in Montreal developing diagnostic tests for primary osteoarthritis and new disease-modifying osteoarthritis drugs. Dr. Moreau’s primary research interests also target other complex adult diseases such as osteoarthritis and myalgic encephalomyelitis.
National Network Coordinator, Iona Worden-Driscoll
Photo: National Network Coordinator, Iona Worden-Driscoll
National Network Coordinator, Iona Worden-Driscoll Iona Worden-Driscoll holds a BSc in Mathematics and Statistics and an MBA from Dalhousie University (Halifax, Nova Scotia, Canada). She has extensive management and research experience, having worked as a coordinator for other CIHR-funded research networks and an operations manager and research consultant within industry. She oversees the functioning of the ICanCME Research Network's activities as well as provides a liaison between network members and stakeholders with the view to identify opportunities for increased partnership and collaboration.

Interested in participating in research?

Logo for RTI International
Data Management and Coordinating Center
RTI International (RTI) leads the Data Management and Coordinating Center (DMCC) for the multi-center ME/CFS Collaborative Research Network. In this capacity, RTI will provide advanced computing systems and expertise to bring together research data from the CRCs into a unified multi-omic database, which combines information from studies looking at genes, proteins, immune function, etc. This data management, analytic support, and coordination will promote the development of new ideas to enhance ME/CFS research by augmenting existing CRC expertise and fostering partnerships among the CRCs and the broader research community.
RTI will foster increased transparency and collaboration within the ME/CFS community by coordinating the Network's community outreach activities and hosting a public website. RTI, a large nonprofit research institute, has served as a data coordinating center for more than 40 multi-site/multi-study research networks, including networks focused in maternal and child health, traumatic brain injury, pelvic floor disorders, blood banking and transfusion medicine, sickle cell disease, Zika virus, and other emerging health challenges.
Photo: RTI Data Management and Coordinating Center team RTI Data Management and Coordinating Center team

Partnerships

RTI is partnering with Solve ME/CFS Initiative to engage the patient community in its research efforts.

Center Director, Linda Morris Brown, MPH, DrPH
Photo: Center Director, Linda Morris Brown, MPH, DrPH
Center Director, Linda Morris Brown, MPH, DrPH Linda Morris Brown, MPH, DrPH, is a senior research epidemiologist at RTI International. In this capacity, Dr. Brown directs data coordinating centers for large multi-site clinical trials and epidemiologic studies; conducts epidemiologic research and analyzes epidemiologic data for large-scale, multi-disciplinary studies in the United States and worldwide; and performs quality assurance data audits of health data. Dr. Brown is the Center Director for RTI's Data Management and Coordinating Center for the ME/CFS Collaborative Research Network. Before joining RTI, Dr. Brown served for 30 years as a Commissioned Officer in the U.S. Public Health Service at the National Cancer Institute at the National Institutes of Health and was Assistant Chief in the Division of Cancer Epidemiology and Genetics for 10 years.
Center Associate Director, Matthew Schu, PhD
Photo: Center Associate Director, Matthew Schu, PhD
Center Associate Director, Matthew Schu, PhD Matthew Schu, PhD, is a Statistical Geneticist whose research focuses on leveraging large datasets of study participants to advance discovery in human health. At RTI International, Dr. Schu is the Director of the Omics, Epidemiology, and Analytics Program within the Genomics, Bioinformatics, and Translational Research Center. In this capacity, he leads a team of researchers whose diverse project work involves collecting data from multiple biological and clinical domains and then integrating these data via statistical models to provide meaningful insights into key questions of health and human disease. Dr. Schu brings his data integration expertise to the ME/CFS Research Network by leading efforts such as the development of the mapMECFS data portal that enables researchers to share and search data from a wide range of biological assay results.
Center Clinical Director, Peter Rowe, MD
Photo: Center Clinical Director, Peter Rowe, MD
Center Clinical Director, Peter Rowe, MD Peter Rowe, MD, is a Professor of Pediatrics at the Johns Hopkins University School of Medicine. He also serves as the director of the chronic fatigue clinic at Johns Hopkins Children's Center. His research focuses on ME/CFS, and he is particularly interested in the association between circulatory abnormalities and ME/CFS symptoms and in the ability of biomechanical movement restrictions to provoke immediate and late symptom aggravation. He received a 2014 research award from the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis for his clinical and scientific work on ME/CFS and related disorders. As Center Clinical Director for RTI's DMCC, Dr. Rowe provides an experienced medical perspective and supports the ME/CFS Research Network's community outreach and data harmonization activities.

Interested in participating in research?

Funding provided through grants U54-AI-138370, U54-NS-105539, U54-NS-105541, and U24-NS-105535 supported by:

National Center for Advancing Translational Sciences (NCATS)
National Center for Complementary and Integrative Health (NCCIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
Office of the Director (OD)

Grants that fund MECFSnet are managed by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases and the National Institute of Neurological Disorders and Stroke. This website was supported by a grant from NIH, grant #U24-NS-105535.

Logo for National Institute of Health (NIH)

Website design and development by RTI International. RTI is a registered trademark and trade name of Research Triangle Institute. The RTI logo is a registered trademark of Research Triangle Institute.

Logo for RTI International

What is ME/CFS?

Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS), is a multi-system disease that causes dysfunction of the neurological, immune, endocrine, and energy metabolism systems.